Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASCA: Prophylactic Amiodarone for Shockable Cardiac Arrest
NCT04845607Phase 3Unknown
- Start
- Apr 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amiodarone in ventricular arrhythmia (VA) and cardiac arrest (SCA) (2 arms). Primary endpoint: Number of patients with re-arrest by shockable rhythm at 5 days. Status: unknown.
02
Drugs
amiodarone
03
Conditions
ventricular arrhythmia (VA)cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT04845607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04845607.